Objective: Cushing's syndrome (CS) is associated with neuropsychological deficits. As the cerebellum plays a key role in neuropsychological functions it may be affected in CS. The aim of this study was to investigate whether patients with CS have a smaller cerebellar volume than healthy controls, and to analyse whether cerebellar volume is associated with neuropsychological performance and clinical parameters. Design: A cross-sectional study was performed. Methods: Thirty-six CS patients (15 with active CS and 21 with CS in remission) and 36 controls matched for age, sex, and education underwent neuropsychological testing, quality of life assessment, clinical evaluation, and magnetic resonance imaging brain scan. Cerebellar volumes (white matter and cortex, bilateral) were calculated using FreeSurfer Software. Results: Patients with active CS showed smaller bilateral cerebellar cortex volumes than controls (left, PZ0.035 and right, PZ0.034), as well as a trend toward smaller right cerebellar cortex volumes than patients in remission CS (PZ0.051). No differences were observed in the volume of cerebellar white matter between the three groups. Both right and left cerebellar cortex volumes correlated negatively with triglyceride levels (right: rZK0.358, PZ0.002 and left: rZK0.317, PZ0.005) and age at diagnosis (right: rZK0.433, PZ0.008 and left: rZK0.457, PZ0.005). Left cerebellar cortex volume also correlated positively with visual memory performance (rZ0.245, PZ0.038). Right cerebellar cortex volume positively correlated with quality-of-life scores (rZ0.468, PZ0.004). Conclusions: The cerebellar cortex volume is smaller in active CS patients than in controls. This finding is associated with poor visual memory and quality of life and is mostly pronounced in patients with higher triglyceride levels and older age at diagnosis.
Chronic exposure to excess glucocorticoids can exert a neurotoxic effect (10, 11) . In CS, this has been specifically associated with aging-like effects on the brain (12) . Aging is associated with annual decreases in the volume of whole brain, the hippocampus, and the cerebellum (13, 14, 15) . Whole brain and hippocampal atrophy and neuropsychological dysfunction have been described in CS, but consensus is lacking about the reversibility of the effects of cortisol on the brain after biochemical control (6, 7, 8, 9, 16, 17, 18, 19) . Furthermore, information regarding the cerebellum in CS is scarce. A 1971 study suggested that cerebellar atrophy was involved in CS, but no neuropsychological evaluation was performed and imaging techniques were not as precise as they are today (20) .
The cerebellum has classically been associated with coordination, motor control, and muscle tone adjustments during movement to keep balance. However, it has long been suspected that the cerebellum has other roles, not only because it has multiple connections to cortical and subcortical brain regions, but also because more than half of the brain neurons are located in the cerebellum (21) . Recently, the cerebellum has been related to emotional control and cognition, and linked to frontal/ executive functions, visuospacial skills, visual memory, verbal working memory, declarative and procedural memory, information processing speed, language, fluency, and emotional processing (21, 22, 23) . Cerebellar atrophy has been found in depression and in posttraumatic stress disorder, conditions in which hypercortisolism seems to have an important role (24) . A reduction in cerebellar volumes has also been observed in patients with rheumatoid arthritis, a population that requires long-term glucocorticoid treatment (25) . Taken together, these data suggest that hypercortisolism is involved in cerebellar volume reduction.
Our aim was to investigate whether patients with CS have a smaller cerebellar volume than healthy controls, and to analyse whether cerebellar volume is associated with neuropsychological performance, clinical parameters, and cortisol levels.
Patients and methods

Patients
CS patients who were routinely followed at Hospital de la Santa Creu i Sant Pau were recruited during their routine endocrinology visits. Healthy controls were donors from the blood donor service and individuals who had participated in previous studies at the center. All patients and controls gave signed informed consent to participate in the study, which was approved by the Hospital Ethics Committee.
Thirty-six CS patients (15 patients with active CS and 21 with CS in remission) and 36 matched controls were included in the study (Table 1) . Each patient was matched to a control participant of the same sex, age (G3 years), and years of education (G3 years) to prevent the influence of age, sex, and education level. All patients and controls were right handed as the study involved brain magnetic resonance imaging (MRI; Edinburgh Handness Inventory O80) (26) . Exclusion criteria for both CS patients and controls were as follows: age O65 years, growth hormone (GH) deficiency, history of drug or alcohol abuse, brain damage, and severe psychiatric or neurological illness. Diabetes mellitus was also considered as an exclusion criterion as it has been associated with a reduction in cerebellar volume (27) . For controls, exclusion criteria additionally included history of endocrine disease or glucocorticoid exposure.
CS patients were considered in remission after surgery if they presented adrenal insufficiency or if morning cortisol suppression (!50 nmol/l) was observed after 1 mg dexamethasone overnight (28) , and if repeated Clinical interview, neuropsychological assessment, and biochemistry
Patients and controls underwent a complete clinical interview that included demographic and clinical data, family and medical history, current medical treatment and blood pressure, height, weight, and waist circumference assessment. CS patients were also asked about the history of their disease. Information was completed with data collection from their clinical files. Duration of hypercortisolism was estimated as the time from symptom onset (in months) to the date of hypercortisolism remission (or current date in active patients), as previously described (9) . The time from symptom onset was estimated through a detailed patient interview and from review of clinical notes and photographs. Delay to diagnosis was considered as the time from symptom onset (in months) to the date of diagnosis of CS.
Both patients and controls performed a battery of neuropsychological tests related to cerebellar functions. CS patients also completed a disease-specific qualityof-life questionnaire, the Cushing QoL (29) . All neuropsychological assessments were performed by the same neuropsychologist (A Santos) to avoid inter-examiner variability.
The participants underwent blood and urine tests. We used a 24-h collection to assess urinary free cortisol using Volumetric segmentation was performed automatically using FreeSurfer version 4.3.1 Image Analysis Software (http://surfer.nmr.mgh.harvard.edu/). This software is composed of 170 HP blades with two quad-cores CPU (Hewlett Packard), each one with 16 GB of RAM, running over Scientific Linux version 5 (https://www.scientificlinux.org/). FreeSurfer processing includes motion correction, removal of non-brain tissue using a hybrid watershed/surface deformation procedure (30) , automated Talairach transformation, and segmentation of the subcortical white matter and deep grey matter volumetric structures (31, 32) . Postprocessing was launched using the PICNIC tool (https://neuroweb.pic.es). Both the automated image processing and the visual check were done by a single, blinded investigator.
All volumetric scores where normalized to the estimated intracranial volume of each individual, as previously described (9) .
Statistical analysis
Statistical analysis was performed using IBM SPSS 21 Software (SPSS, Inc.). Normal distribution was analyzed using the Kolmogorov-Smirnov test. Comparisons between groups were performed using ANOVA followed by a Bonferroni's correction. Differences were considered significant when P!0.05. The c 2 test was used to compare categorical variables, and correlations were assessed using Pearson's coefficient. Data are reported as meanGS.D. Direct scores of the tests were transformed into Z-scores to obtain a general score for each cognitive function. The general scores for each cognitive function were obtained by calculating the mean between the Z-scores of the tests included for each cognitive function. Tests in which higher scores were not related to a better performance were inverted.
Results
No differences were found between groups for age, sex, or education level. Table 1 summarizes clinical and demographic characteristics of CS patients and controls.
Patients in remission included 21 CS patients (17 females) who achieved cure of their hypercortisolism after treatment: 18 were of pituitary origin and three of adrenal origin. At the time of the study, six were on hydrocortisone therapy for adrenal insufficiency after surgery, five were taking antidepressants, and five had had previous radiotherapy.
Active patients included 15 CS patients (13 females) with active hypercortisolism: ten of pituitary origin, three of adrenal origin, one ectopic adrenocorticotropic hormone (ACTH) secretion of unknown origin, and one ACTH-independent macronodular adrenal hyperplasia (AIMAH). Fourteen of the 15 active patients were taking medication: 11 were on ketoconazole or metyrapone treatment, one was taking cabergoline, one was taking losartan treatment (a patient with AIMAH who responded to angiotensin receptor antagonists), and one was taking antidepressants.
Total cerebellar volume was calculated. Both grey matter (cortex) and white matter were analyzed separately 
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for each cerebellar hemisphere. Table 3 shows mean cerebellar volumes. No differences were found between groups for total cerebellar volumes. However, in patients with active CS, cerebellar cortex volumes were smaller than those in controls (left, PZ0.035 and right, PZ0.034). The results did not change when the patient taking antidepressants and the corresponding healthy control were excluded from the analysis (left, PZ0.046 and right, PZ0.032). In contrast, cerebellar cortex volumes in CS patients in remission did not differ from those in controls. When the two CS patient groups were compared, active patients also tended to have a smaller right cerebellar cortex volume than patients in remission (PZ0.051). No differences were found in cerebellar white matter volumes between the three groups. Figure 1 shows an example of the MRI of a patient and her matched control.
Regarding neuropsychological functions, patients with active CS had a poorer performance in visual memory than controls (PZ0.006), and a tendency for poorer performance when compared with patients in remission (PZ0.066). Visual memory correlated with left cerebellar cortex volumes (rZ0.245, PZ0.038). No difference between groups was found for other functions (fine motor skills, visuoconstructive function, language, information processing speed, or executive function; Fig. 2 ). Table 4 gives mean and S.D.s of each neuropsychological test. Furthermore, both patient groups had more depression (both P!0.001) and anxiety scores than controls (STAI State, PZ0.014 for active CS and PZ0.024 for patients in remission; STAI Trait, P!0.001 for both patient groups), although no difference was found between patients with active disease or those in remission. No correlation was found between these scores and cerebellar volumes.
Regarding clinical parameters, active CS patients had higher urinary free cortisol (P!0.001), triglycerides (PZ0.010), waist circumference (PZ0.001), systolic blood pressure (PZ0.006), and diastolic blood pressure (P!0.001) than controls. CS patients in remission showed higher waist circumference (PZ0.031), systolic blood pressure (PZ0.002), and diastolic blood pressure (P!0.001) than controls. They also showed a tendency to higher triglycerides (PZ0.062). When the whole sample was analyzed, only triglycerides correlated negatively with right and left cerebellar cortex volumes (right: rZK0.358, PZ0.002 and left: rZK0.317, PZ0.005). Both right and 
Discussion
CS is associated with a decrease in whole brain and hippocampal volumes, although its reversibility after biochemical control of hypercortisolism is still a matter of debate (9, 16, 18, 19, 33) . In this study, we found that the cerebellar cortex (grey matter) was smaller in patients with active hypercortisolism than in control individuals. Glucocorticoids have been linked to cell death in brain regions such as the cerebellum and hippocampus (34) .
They are also known to impair neurogenesis, present in both these structures (35) . Glucocorticoids and stress can also modify dendritic structure, reducing synapsis and dendritic atrophy (dendritic simplification and retraction) (36, 37) . As dendrites are part of the cortex, our results could also be explained by a reduction in dentrites induced by glucocorticoids.
In contrast with these findings in active patients, the cerebellar cortex was not smaller in CS patients in remission. Based on these data, we can speculate that hypercortisolemia leads to cerebellar shrinkage, which may be partially reversible after cure. Several studies have found that hippocampal volume increases after cure, so it is feasible that other brain structures may also improve after remission (16, 19) . Our results are in line with a recent study in CS patients in remission that did not find the volume of cerebellar grey matter was smaller. In fact, the authors reported that the left posterior lobe of the cerebellum was larger (33) . They suggested that neuronal reorganization after chronic stress could lead to dendrite atrophy in parts of the brain or to dendritic hypertrophy in others. This could explain the larger cerebellar volume that they found in contrast with smaller volumes in 
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other structures. Following this hypothesis, even if dendritic atrophy occurred during the active phase of the disease, it could be compensated by a dendritic hypertrophy after biochemical cure. Longitudinal studies would be necessary to confirm these hypotheses. In this study, smaller cerebellar cortex volumes were associated with several clinical variables. First, age at diagnosis correlated negatively with cerebellar volume, meaning that the volume of cerebellar cortex was smaller in patients who were diagnosed at an older age. Current age did not correlate with cerebellar volumes in active patients or in patients in remission, so the correlation with age at diagnosis may be related to other factors, such as exposure to hypercortisolism. The capacity for neurogenesis decreases significantly throughout life (38) . Exposure to glucocorticoids at a later age may therefore be related to an increased risk of cerebellar reduction, as the capacity of neurons to regenerate is reduced with aging.
Second, we found a negative correlation between triglyceride levels and the volume of the cerebellar cortex, meaning that elevated triglycerides were related to a smaller cerebellar cortex volume. This is consistent with a study in which rats fed a medium-chain triglyceride supplemented diet had an aging-like effect in the cerebellar cortex, leading to a lower number of synapsis and synaptic mitochondria (39) . The authors claimed that this diet could have aging or anti-aging effects, depending on the neuronal vulnerability of the cells, and the cerebellar cortex is particularly vulnerable to age. Therefore, high triglyceride levels, together with cortisol exposure, could have an aging-like effect in the cerebellar cortex in CS patients, leading to a volumetric reduction. Control of triglyceride levels may be helpful to avoid cerebellar impairment. However, further studies on dyslipidemia and cerebellar function are needed.
Third, quality of life, evaluated with the diseasespecific Cushing QoL questionnaire, correlated directly with right cerebellar cortex volume. This relation between quality of life and cerebellar cortex has not been reported previously, but since the cerebellum plays a role in the modulation of emotional responses (23) , it may also be involved in self-perceived quality of life. In patients with right cerebellar insults, lesion size has been correlated with the severity of depression (40) . Indeed, the cerebellum has been associated with emotional processing. Although we did not find any correlation between depression and cerebellar cortex, it is feasible that there may be a certain degree of lateralization for emotional processing, mood, and depression in the cerebellum.
Regarding neuropsychological results, visual memory performance correlated with left cerebellar cortex volume.
Even if memory has classically been related to the hippocampus, the cerebellum also seems to play a role in visual memory (21, 23) . Specifically, visuospatial memory has been associated with the left-superior-posterior lobe of the cerebellum in both children with early deprivation and normal children (41) . Our data show that patients with smaller left cerebellar volumes have poorer visual memory skills. This could lead to problems such as difficulties in remembering information from maps, or losing one's way in unknown places. These findings may have implications during the diagnostic process because neuropsychological impairment may be present. Apart from a neuropsychological evaluation, a detailed neurological examination may be helpful to identify further impairment.
It is also of note that patients in remission showed poorer neuropsychological performance than active patients in language and information processing speed, although this difference was not statistically significant. CS predisposes to chronic inflammation and cerebrovascular disease, even after cure (42) . Long-term inflammation has been associated with impaired information processing speed (43) , while cerebrovascular disease can lead to vascular dementia. Interestingly, in patients with vascular dementia, language function progressively declines (44) . Patients in remission have been exposed to inflammation and cerebrovascular risk for a longer time than active patients, which may explain their worse performance. As language tends to be more preserved than information processing speed with normal aging (45) , it is conceivable that newly diagnosed patients with active hypercortisolism still maintain normal language function.
A smaller cerebellar volume may have other clinical implications. As this portion of the brain is related to motor control and gait, a smaller volume might account for poor postural control and balance deficits in these patients (46, 47) . These deficits may be even more severe in patients with obesity, a symptom also related to impaired balance and postural control (48) and to more falls than in normal-weight subjects (49) . The risk of falls should be kept in mind in patients with CS as they have a higher incidence of osteoporosis and therefore a higher risk of fracture. The risk of falls should be specially considered in older patients, as it has been associated with higher morbidity, greater use of health care resources, and even a higher mortality (50) . It would be interesting in the future to prospectively study the relationship between cerebellar volume and the number of falls.
This study has several limitations. The first one is the small sample size and the heterogeneity of the sample, challenges inherent to a rare disease such as CS. The number of patients included in the study was further reduced by the strict exclusion criteria. However, this restriction avoided the influence of factors which could affect cerebellar volume, such as diabetes mellitus, GH deficiency, older age, brain damage, history of drug or alcohol abuse, and severe psychiatric or neurological illnesses. The second limitation is that FreeSurfer is an automatic technique and it may not be as accurate as manual segmentation. It is feasible that measurement noise may have masked clearer correlations with clinical and neuropsychological parameters. A further limitation is that we did not perform a standard neurological evaluation, and such a study might have identified subtle cerebellar dysfunction in these CS patients. A final potential weakness is the cross-sectional design of the study. Longitudinal studies could also confirm whether the cerebellar cortex volume in active patients increases after cure, and if so, how long this takes to occur. Studies analysing the possible benefits of neuropsychological rehabilitation could also lead to improvements in QoL and neuropsychological functions.
In conclusion, we found that patients with active CS have a smaller cerebellar cortex, associated with poorer visual memory, decreased QoL, higher blood triglyceride levels, and older age at diagnosis. The absence of this volumetric reduction in patients in remission is encouraging, suggesting that it may be reversible, at least in part, after cortisol normalization.
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